Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment
出版年份 2011 全文链接
标题
Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 11, Issue 4, Pages 589-607
出版商
Informa UK Limited
发表日期
2011-04-07
DOI
10.1586/ern.10.191
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of Preoperative Symptom Profile With Psychiatric Symptoms Following Subthalamic Nucleus Stimulation in Patients With Parkinson's Disease
- (2014) Omer Porat et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Science and Recovery in Schizophrenia
- (2014) Jeffrey A. Lieberman et al. PSYCHIATRIC SERVICES
- Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial
- (2010) Chuan-Yue Wang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study
- (2010) Abraham Reichenberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis
- (2010) Surendra P. Singh et al. BRITISH JOURNAL OF PSYCHIATRY
- Aripiprazole in schizophrenia and schizoaffective disorder: A review
- (2010) Emmanuel Stip et al. CLINICAL THERAPEUTICS
- Pregnenolone, Dehydroepiandrosterone, and Schizophrenia: Alterations and Clinical Trials
- (2010) Michael S. Ritsner CNS Neuroscience & Therapeutics
- Polypharmacy in schizophrenia
- (2010) Mathias Zink et al. CURRENT OPINION IN PSYCHIATRY
- Neurodegeneration in schizophrenia
- (2010) Trevor Archer Expert Review of Neurotherapeutics
- Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004
- (2010) Franca Centorrino et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia
- (2010) Robert H. Pietrzak et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- RG3487, a Novel Nicotinic 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
- (2010) T. L. Wallace et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers
- (2010) Pei Chun Hsieh JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia
- (2010) Jun Kosaka et al. LIFE SCIENCES
- Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: A [I-123]FP-CIT SPECT study
- (2010) Flavio Nobili et al. MOVEMENT DISORDERS
- A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia
- (2010) Eleanor H. Simpson et al. NEURON
- Course of neurocognitive deficits in the prodrome and first episode of schizophrenia.
- (2010) Carol Jahshan et al. NEUROPSYCHOLOGY
- Reversal of neuronal and cognitive consequences of amphetamine sensitization following chronic treatment with a D1 antagonist
- (2010) Lynn D. Selemon et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Combination Therapy in the Treatment of Schizophrenia
- (2010) C. Wolff-Menzler et al. PHARMACOPSYCHIATRY
- Rapid response to antipsychotic treatment on psychotic prodrome: Implications from a case series
- (2010) Chen-Chung Liu et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: Clinical-onset implications
- (2010) José María Pelayo-Terán et al. PSYCHIATRY RESEARCH
- Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis
- (2010) José María Pelayo-Terán et al. PSYCHIATRY RESEARCH
- Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists
- (2010) Brooke M. Roberts et al. PSYCHOPHARMACOLOGY
- Early developmental milestones and risk of schizophrenia: A 45-year follow-up of the Copenhagen Perinatal Cohort
- (2010) Holger J. Sørensen et al. SCHIZOPHRENIA RESEARCH
- Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: Involvement of dopamine D1 receptors
- (2010) Kent Jardemark et al. SYNAPSE
- Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons
- (2010) Jian-Li Hu et al. Molecular Brain
- In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
- (2009) Susanne Nikolaus et al. BEHAVIOURAL BRAIN RESEARCH
- Reward Processing After Catecholamine Depletion in Unmedicated, Remitted Subjects with Major Depressive Disorder
- (2009) Gregor Hasler et al. BIOLOGICAL PSYCHIATRY
- Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects
- (2009) Anissa Abi-Dargham et al. BIOLOGICAL PSYCHIATRY
- Progress in Defining Optimal Treatment Outcome in Schizophrenia
- (2009) Gary Remington et al. CNS DRUGS
- Intervention in the at-risk state to prevent transition to psychosis
- (2009) Stephan Ruhrmann et al. CURRENT OPINION IN PSYCHIATRY
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
- (2009) Morten Thomsen et al. CURRENT PHARMACEUTICAL DESIGN
- α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine releasein vitroandin vivoin the rat prefrontal cortex
- (2009) Phil D. Livingstone et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Drugs in development for the treatment of schizophrenia
- (2009) Robin Emsley EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Is there a degenerative process going on in the brain of people with schizophrenia?
- (2009) Bjorn Rund Frontiers in Human Neuroscience
- Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness
- (2009) Rachel Scornaiencki et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Monthly Administration of Long-Acting Injectable Risperidone and Striatal Dopamine D2 Receptor Occupancy for the Management of Schizophrenia
- (2009) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia
- (2009) Philip G. Janicak et al. JOURNAL OF CLINICAL PSYCHIATRY
- Intervention in Individuals at Ultra-High Risk for Psychosis
- (2009) Patrick D. McGorry et al. JOURNAL OF CLINICAL PSYCHIATRY
- Apathy and Depression in Parkinson Disease
- (2009) Miyako Oguru et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study
- (2009) Kenn Freddy Pedersen et al. JOURNAL OF NEUROLOGY
- Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study
- (2009) K F Pedersen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
- (2009) Maria C Rodriguez-Oroz et al. LANCET NEUROLOGY
- The subthalamic nucleus is a key-structure of limbic basal ganglia functions
- (2009) Claire Haegelen et al. MEDICAL HYPOTHESES
- The syndromal validity and nosological position of apathy in Parkinson's disease
- (2009) Sergio E. Starkstein et al. MOVEMENT DISORDERS
- Neuropsychiatric symptoms in Parkinson's disease
- (2009) Dag Aarsland et al. MOVEMENT DISORDERS
- Subthalamic nucleus stimulation in Parkinson disease induces apathy: A PET study
- (2009) F. Le Jeune et al. NEUROLOGY
- Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: Effects of pramipexole and pergolide on working memory
- (2009) Alberto Costa et al. NEUROPSYCHOLOGIA
- Pharmacological Cognitive Enhancement in Schizophrenia
- (2009) Philip D. Harvey NEUROPSYCHOLOGY REVIEW
- Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia
- (2009) Daniel J. Lodge et al. NEUROTOXICITY RESEARCH
- Presynaptic Regulation of Dopamine Transmission in Schizophrenia
- (2009) G. J. Lyon et al. SCHIZOPHRENIA BULLETIN
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Is Early Intervention in Psychosis Cost-Effective Over the Long Term?
- (2009) C. Mihalopoulos et al. SCHIZOPHRENIA BULLETIN
- Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond
- (2009) E. Bora et al. SCHIZOPHRENIA BULLETIN
- The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
- (2009) S. H. Fatemi et al. SCHIZOPHRENIA BULLETIN
- Motivational deficits as the central link to functioning in schizophrenia: A pilot study
- (2009) G. Foussias et al. SCHIZOPHRENIA RESEARCH
- The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample
- (2009) Elaine F. Walker et al. SCHIZOPHRENIA RESEARCH
- Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2receptor in vitro
- (2009) Patrick N. McCormick et al. SYNAPSE
- Introduction: Genes, cognition and neuropsychiatry
- (2009) Brita Elvevåg et al. Cognitive Neuropsychiatry
- Prefrontal cognitive systems in schizophrenia : Towards human genetic brain mechanisms
- (2009) Hao-Yang Tan et al. Cognitive Neuropsychiatry
- Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study
- (2008) Gerhard Gründer et al. AMERICAN JOURNAL OF PSYCHIATRY
- Prediction of Psychosis in Youth at High Clinical Risk
- (2008) Tyrone D. Cannon et al. ARCHIVES OF GENERAL PSYCHIATRY
- Glycine Transport Inhibitors and the Treatment of Schizophrenia
- (2008) Daniel C. Javitt BIOLOGICAL PSYCHIATRY
- Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
- (2008) Anne-Noël Samaha et al. BIOLOGICAL PSYCHIATRY
- Disconnecting force from money: effects of basal ganglia damage on incentive motivation
- (2008) Liane Schmidt et al. BRAIN
- Upcoming Agents for the Treatment of Schizophrenia
- (2008) Delia Bishara et al. DRUGS
- AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures
- (2008) Erik Boot et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Emerging drugs for schizophrenia
- (2008) Ofer Agid et al. EXPERT OPINION ON EMERGING DRUGS
- D1 and D4 dopaminergic receptor interplay mediates coincident G protein-independent and dependent regulation of glutamate NMDA receptors in the lateral amygdala
- (2008) Marzia Martina et al. JOURNAL OF NEUROCHEMISTRY
- The —1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients
- (2008) L. Wang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Prolactin and dopamine: What is the connection? A Review Article
- (2008) Peter Fitzgerald et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Non-dopaminergic treatments in development for Parkinson's disease
- (2008) Susan H Fox et al. LANCET NEUROLOGY
- COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET
- (2008) M Slifstein et al. MOLECULAR PSYCHIATRY
- Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom
- (2008) Virginie Czernecki et al. MOVEMENT DISORDERS
- The history of dopamine and levodopa in the treatment of Parkinson's disease
- (2008) Stanley Fahn MOVEMENT DISORDERS
- Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database
- (2008) Nicole C Allen et al. NATURE GENETICS
- The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
- (2008) Ariel Graff-Guerrero et al. NEUROPSYCHOPHARMACOLOGY
- D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats
- (2008) Nathalie Ginovart et al. NEUROPSYCHOPHARMACOLOGY
- Dynamic changes in accumbens dopamine correlate with learning during intracranial self-stimulation
- (2008) C. A. Owesson-White et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent advances in treating cognitive impairment in schizophrenia
- (2008) Cherrie Galletly PSYCHOPHARMACOLOGY
- Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature
- (2008) J. M. Stone et al. SCHIZOPHRENIA BULLETIN
- Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
- (2008) G. Foussias et al. SCHIZOPHRENIA BULLETIN
- Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North America Double Blind Treatment Study
- (2008) Keith A. Hawkins et al. SCHIZOPHRENIA RESEARCH
- Estimation of Baseline Dopamine D2 Receptor Occupancy in Striatum and Extrastriatal Regions in Humans with Positron Emission Tomography with [18F] Fallypride
- (2007) Patrizia Riccardi et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started